» Articles » PMID: 15922854

Survivin As Prognostic Factor in Squamous Cell Carcinoma of the Oral Cavity

Overview
Journal Cancer Lett
Specialty Oncology
Date 2005 Jun 1
PMID 15922854
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

A series of 78 cases of oral squamous cell carcinoma was analysed by immunohistochemistry for expression of survivin, a recent apoptosis inhibitor. All cases were positive for survivin expression and were divided into two groups using a system of scores. Disease-specific survival curves were calculated according to Kaplan-Meier algorithm, and log rank test was used to compare survival curves. Then, Cox regression analysis was applied to determine the single contribution of covariates on survival rate. So, Cox analysis allowed us to detect the variables most associated to survival. Among the studied variables, such as grade of differentiation, tumor size, stage, recurrence of disease, lymph node presence, only stage and recurrence of disease were predictors of outcome; however, when we analyzed the survival without considering recurrence (that was the stronger predictor of death), a stepwise Cox analysis showed that Survivin, stage and grade of differentiation are significantly associated to survival, with a higher value for Survivin. These data suggest that survivin expression may identify cases of oral squamous cell carcinoma with more aggressive and invasive phenotype and, therefore, could influence the decision for the therapy at the time of diagnosis.

Citing Articles

The prognostic significance of survivin expression in patients with HNSCC: a systematic review and meta-analysis.

Zhou L, Hu Y, Xiao H BMC Cancer. 2021; 21(1):424.

PMID: 33863308 PMC: 8052826. DOI: 10.1186/s12885-021-08170-3.


Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study.

Rajanna V, Raveendranath M, Kathiresan S, Srinivasan S, Ilango J J Pharm Bioallied Sci. 2020; 12(Suppl 1):S382-S388.

PMID: 33149491 PMC: 7595508. DOI: 10.4103/jpbs.JPBS_114_20.


Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma.

Troiano G, Guida A, Aquino G, Botti G, Losito N, Papagerakis S Int J Mol Sci. 2018; 19(9).

PMID: 30205554 PMC: 6174346. DOI: 10.3390/ijms19092664.


Survivin-Based Treatment Strategies for Squamous Cell Carcinoma.

Santarelli A, Mascitti M, Russo L, Sartini D, Troiano G, Emanuelli M Int J Mol Sci. 2018; 19(4).

PMID: 29587347 PMC: 5979467. DOI: 10.3390/ijms19040971.


Expression of survivin and p53 in oral lichen planus, lichenoid reaction and lichenoid dysplasia: An immunohistochemical study.

Basheer S, Shameena P, Sudha S, Varma S, Vidyanath S, Varekar A J Oral Maxillofac Pathol. 2018; 21(3):456-457.

PMID: 29391729 PMC: 5763877. DOI: 10.4103/jomfp.JOMFP_39_15.